Shearman & Sterling advised Boston Scientific Corporation, as borrower, in connection with a $3 billion financing, including a refinancing of its $2 billion revolving credit facility arranged by J.P. Morgan Securities LLC and Merrill Lynch, Pierce, Fenner & Smith Incorporated, a new $750 million unsecured term loan arranged by J.P. Morgan Securities LLC and Merrill Lynch, Pierce, Fenner & Smith Incorporated, which backs the company's acquisition of Endo International's male urology business, and a $250 million revolving credit facility arranged by J.P. Morgan Securities LLC.

The Team